`
`Applicant: MARUYAMA et al.
`
`Docket:
`
`20249.0116USD1
`
`Filed:
`
`Herewith
`
`Title:
`
`ANALYSIS REAGENT AND ANALYSIS DEVICE HAVING THE
`
`ANALYSIS REAGENT CARRIED THEREIN
`
`CERTIFICATE OF TRANSMISSION
`I hereby certify that this paper is being transmitted by EFS Web to: Commissioner for Patents, PO. Box 1450, Alexandria, VA
`22313—1450 on September 8, 2014.
`
`Name: Chieko Rogers
`
`By:
`
`/Chieko Rogers/
`
`INFORMATION DISCLOSURE STATEMENT
`
`Commissioner for Patents
`
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`Sir:
`
`With regard to the above-identified application, the items of information listed on
`the enclosed Form SB08 are brought to the attention of the Examiner.
`
`In accordance with the provisions of 37 C.F.R. 1.98(d) a copy of each document
`or other information listed on the enclosed Form SB08 is not provided for those that were
`previously cited by or submitted to the US. Patent and Trademark Office in parent
`application, U.S. Serial No. 13/380427 filed on December 22, 2011.
`
`In accordance with the provisions of 37 C.F.R. §1.97, this statement is being filed
`(CHECK ONE):
`
`IXI
`
`(1) within three (3) months of the Filing Date, before the mailing date of a First
`Office Action on the merits, or before the mailing date of a First Office
`Action on the merits after the filing of a request for continued examination
`under 37 C.F.R. §1.114; or
`
`D (2) after the period defined in (1) but before the mailing date of a Final
`Rejection or Notice of Allowance, and
`
`D the requisite Statement is below, OR
`
`D the requisite fee of $180.00 under Rule 1.17(p) is included herein, or
`
`D (3) after the mailing date of a Final Rejection or Notice of Allowance but on or
`before the payment of the Issue Fee, AND the requisite Statement is below
`AND the requisite fee of $180.00 under Rule 1.17(p) is included herein.
`
`
`
`STATEMENT
`
`Applicants hereby state that:
`
`D
`
`Each item of information contained in the Information Disclosure
`Statement was first cited in a communication from a foreign patent office
`in a counterpart application or by the USPTO in a related application not
`more than three months prior to the filing date of the Information
`Disclosure Statement
`
`D If this box is checked, Applicant provides the following:
`
`Certification Under 37 C.F.R. §1.704gd1
`
`In accordance with 37 C.F.R. §1.704(d), the undersigned hereby certifies that each
`item listed on the enclosed Form SB08 was first cited in a communication from a
`
`foreign patent office in a counterpart application, and that this communication was
`not received by any individual designated in 37 C.F.R. §1.56(c) more than thirty
`(30) days prior to the filing of this Information Disclosure Statement.
`
`D The Examiner is hereby advised of the following co-pending U.S. applications. A
`copy of each US. patent application publication (if published) or application (if not
`published) is enclosed.
`
`Application No.
`
`Filing Date
`
`Group
`
`No representation is made that a reference is "prior art" within the meaning of 35
`U.S.C. §§ 102 and 103 and Applicants reserve the right, pursuant to 37 C.F.R. § 1.131 or
`otherwise, to establish that the reference(s) are not “prior art.” Moreover, Applicants do
`not represent that a reference has been thoroughly reviewed or that any relevance of any
`portion of a reference is intended.
`
`Consideration of the items listed is respectfully requested. Pursuant to the
`provisions of M.P.E.P. 609, it is requested that the Examiner return a copy of the attached
`Form SB08, marked as being considered and initialed by the Examiner, to the
`undersigned with the next official communication.
`
`
`
`FEE AUTHORIZATION
`
`Please charge any required fee or credit overpayment to Deposit Account No. 50-
`
`3478.
`
`Respectfully submitted,
`
`HAMRE, SCHUMANN, MUELLER &
`
`LARSON, PC.
`PO. Box 2902
`
`Minneapolis, MN 55402-0902
`(612) 455-3800
`
`Dated: September 8, 2014
`
`By:
`
`/Douglas P. Mueller/
`Douglas P. Mueller
`Reg. No. 30,300
`DPM/cmr
`
`53148
`
`